Insider Transactions in Q1 2021 at Arena Pharmaceuticals Inc (ARNA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Laurie Stelzer EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,356
-22.62%
|
$331,056
$76.1 P/Share
|
|
Mar 16
2021
|
Laurie Stelzer EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,600
+39.55%
|
-
|
|
Mar 15
2021
|
Joan Schmidt EVP, General Counsel & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,874
-25.03%
|
$375,298
$77.58 P/Share
|
|
Mar 15
2021
|
Joan Schmidt EVP, General Counsel & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
12,600
+39.28%
|
-
|
|
Mar 01
2021
|
Amit Munshi President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
28,800
+44.07%
|
-
|
|
Mar 01
2021
|
Laurie Stelzer EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,660
+50.0%
|
-
|
|
Mar 01
2021
|
Vincent Aurentz Executive VP and CBO |
BUY
Grant, award, or other acquisition
|
Direct |
6,660
+16.52%
|
-
|
|
Mar 01
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,660
+29.26%
|
-
|
|
Mar 01
2021
|
Joan Schmidt EVP, General Counsel & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
6,660
+49.21%
|
-
|
|
Feb 16
2021
|
Vincent Aurentz Executive VP and CBO |
SELL
Open market or private sale
|
Direct |
2,524
-8.55%
|
$214,540
$85.0 P/Share
|
|
Feb 16
2021
|
Vincent Aurentz Executive VP and CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,524
+3.95%
|
$63,100
$25.1 P/Share
|
|
Feb 12
2021
|
Nawal Ouzren Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,488
+39.28%
|
-
|
|
Feb 02
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,500
-27.21%
|
$1,365,000
$78.52 P/Share
|
|
Feb 02
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+39.38%
|
$700,000
$40.95 P/Share
|
|
Jan 19
2021
|
Jayson Donald Alexander Dallas Director |
SELL
Open market or private sale
|
Direct |
1,327
-20.0%
|
$106,160
$80.5 P/Share
|
|
Jan 19
2021
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-86.58%
|
$4,000,000
$80.14 P/Share
|
|
Jan 19
2021
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.4%
|
$750,000
$15.5 P/Share
|
|
Jan 15
2021
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-54.39%
|
$4,000,000
$80.63 P/Share
|
|
Jan 15
2021
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.4%
|
$750,000
$15.5 P/Share
|
|
Jan 12
2021
|
Amit Munshi President and CEO |
SELL
Open market or private sale
|
Direct |
14,877
-28.72%
|
$1,100,898
$74.87 P/Share
|
|
Jan 07
2021
|
Amit Munshi President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,523
-27.36%
|
$656,271
$77.59 P/Share
|
|
Jan 07
2021
|
Amit Munshi President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,400
+42.9%
|
-
|
|
Jan 07
2021
|
Vincent Aurentz Executive VP and CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+40.0%
|
-
|
|
Jan 07
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,159
-25.07%
|
$243,243
$77.59 P/Share
|
|
Jan 07
2021
|
Robert Lisicki EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,600
+50.0%
|
-
|